POSATEX® Otic Suspension
(orbifloxacin, mometasone furoate monohydrate and posaconazole, suspension)
Highy effective and safe for even the most stubborn cases
A strong, yet gentle solution for severe cases of otitis externa in dogs.
Indications
POSATEX® Otic Suspension is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (coagulase positive staphylococci, Pseudomonas aeruginosa, and Enterococcus faecalis).
Features & Benefits
Triple-action, once-a-day treatment for 7 days for even the most stubborn cases associated with susceptible strains of yeast and bacteria in canines.
ANTIBACTERIAL EFFECT
ORBIFLOXACIN
Effective against a wide variety of Gram-negative and Gram-positive bacteria, including:1 Pseudomonas aeruginosa, coagulase-positive staphylococci, and Enterococcus faecalis
ANTI-INFLAMMATORY ACTION
MOMETASONE FUROATE MONOHYDRATE
An effective corticosteroid that rapidly reduces discomfort, erythema, and swelling1
Rapidly controls inflammation without adrenocortical suppression2
ANTIFUNGAL ACTIVITY
POSACONAZOLE
Highly effective and safe for even the most stubborn cases
Provides potent, broad-spectrum efficacy, including against Malassezia pachydermatis1
POSATEX gets strong performance scores from veterinarians, even on the toughest, most chronic cases of otitis externa.
Results
- POSATEX treatment success rated as excellent in 50% OF ALL CASES.3
- In comparison, veterinarians gave prior treatment an “excellent” score in only 10% of all cases.
Treat otitis externa the first time.
Veterinarians use POSATEX most often to treat recurrent otitis externa and cases with heavy Malassezia infection, and they report excellent treatment results with Posatex.3
Diseases/Parasites
Description
Each gram of POSATEX Otic Suspension contains 10 mg of orbifloxacin; mometasone furoate monohydrate equivalent to 1 mg mometasone furoate; and 1 mg of posaconazole in a mineral oil-based system containing a plasticized hydrocarbon gel.
Administration and Dosage
- Administer once daily for 7 days — Helps ensure pet parent compliance to treatment
- 4 drops per ear for dogs less than 30 lbs
- 8 drops per ear for dogs equal to or greater than 30 lbs
Vehicle
- Solution-like consistency with clear advantage
- Colorless solution is easy to differentiate from exudate
- Eliminates staining
- Hydrocarbon formulation consistency facilitates easy counting of drops for proper dosing
- Ensures prolonged contact at the site of infection
Supplied
POSATEX Otic Suspension is available in 7.5 g, 15 g, and 30 g plastic bottles.
Important Safety Information
POSATEX® Otic Suspension is contraindicated in dogs with known or suspected hypersensitivity to quinolones, mometasone furoate monohydrate, or posaconazole. Do not administer orally. Immediately discontinue use if hearing loss is observed during treatment. Do not use in dogs with known tympanic perforation. Avoid prolonged or repeated use of POSATEX® Otic Suspension. Long-term use of topical otic corticosteroids has been associated with adrenocortical suppression and iatrogenic hyperadrenocorticism in dogs. The safe use in dogs used for breeding purposes, during pregnancy, or in lactating bitches has not been evaluated. Not for use in humans. Keep out of reach of children. For complete safety information, refer to the product label.
References
1. Posatex® Otic Suspension [Orbifloxacin, Mometasone Furoate Monohydrate and Posaconazole] [Product Information]. Madison, NJ: Intervet Inc.; 2019.
2. Reeder CJ, Griffin CE, Polissar NL, et al. Comparative adrenocortical suppression in dogs with otitis externa following topical otic administration of four different corticosteroid-containing medications. Vet Ther. 2008;9:111-121.
3. Data on file, Merck Animal Health.